CTRVP
Hepion Pharmaceuticals, Inc.
Key Financials
Net Income
$-8277850
↑ 37.3%
Operating Income
$-4163691
↑ 78.5%
Total Assets
$3.1M
↑ 90.2%
Revenue
$0
NaN%
EPS (Diluted)
$-0.88
↑ 99.2%
Total Liabilities
$402405.00
↓ 88.4%
Shareholders' Equity
$2.7M
↑ 243.2%
Cash & Equivalents
$13.9M
↑ 391.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 10/2/2026 | View on SEC |
| 8-K | 10/2/2026 | View on SEC |
| 8-K | 9/28/2026 | View on SEC |
| 3 | 9/16/2026 | View on SEC |
| SCHEDULE 13D/A | 9/16/2026 | View on SEC |
| SCHEDULE 13G | 9/15/2026 | View on SEC |
| 4 | 9/14/2026 | View on SEC |
| DEF 14C | 9/10/2026 | View on SEC |
| 4 | 9/10/2026 | View on SEC |
| 8-K | 9/8/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CTRVP |
| Company Name | Hepion Pharmaceuticals, Inc. |
| CIK | 1583771 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 732-902-4000 |